Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome-Reference-Cited by-同舟云学术

Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome

Published:2018-06 Issue:6 Volume:11 Page:
ISSN:2574-8300
Container-title:Circulation: Genomic and Precision Medicine
language:en
Short-container-title:Circ: Genomic and Precision Medicine

Author:

Takeda Norifumi¹,Inuzuka Ryo²,Maemura Sonoko¹,Morita Hiroyuki¹,Nawata Kan³,Fujita Daishi¹,Taniguchi Yuki⁴,Yamauchi Haruo³,Yagi Hiroki¹,Kato Masayoshi¹,Nishimura Hiroshi¹,Hirata Yoichiro²,Ikeda Yuichi¹,Kumagai Hidetoshi¹⁵,Amiya Eisuke¹,Hara Hironori¹,Fujiwara Takayuki¹,Akazawa Hiroshi¹,Suzuki Jun-ichi¹⁵,Imai Yasushi⁶⁷,Nagai Ryozo⁸,Takamoto Shinichi⁹,Hirata Yasunobu¹⁰,Ono Minoru³,Komuro Issei¹

Affiliation:

1. Department of Cardiovascular Medicine (N.T., S.M., H.M., D.F., H. Yagi, M.K., H.N., Y. Ikeda, H.K., E.A., H.H., T.F., H.A., J.-i.S., I.K.),

2. Department of Pediatrics (R.I., Y.H.)

3. Department of Cardiac Surgery (K.N., H. Yamauchi, M.O.)

4. Department of Orthopedic Surgery (Y.T.)

5. Department of Advanced Clinical Science and Therapeutics (H.K., J.-i.S.)

6. The University of Tokyo Hospital, Tokyo, Japan. Division of Clinical Pharmacology, Department of Pharmacology (Y. Imai)

7. Division of Cardiovascular Medicine, Department of Internal Medicine (Y. Imai),

8. Jichi Medical University, Shimotsuke, Tochigi, Japan. Jichi Medical University, Shimotsuke, Tochigi, Japan (R.N.).

9. Mitsui Memorial Hospital, Tokyo, Japan (S.T.).

10. Tokyo Teishin Hospital, Tokyo, Japan (Y.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Guidelines for Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection (JCS 2011)

2. The revised Ghent nosology for the Marfan syndrome

3. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC).;Erbel R;Eur Heart J,2014

4. Determination of the molecular basis of Marfan syndrome: a growth industry

5. Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A de novo FBN1 missense variant associated with a severe phenotype of early onset Marfan syndrome;Progress in Pediatric Cardiology;2024-12

2. The proprotein convertase FURIN is a novel aneurysm predisposition gene impairing TGF-β signalling;Cardiovascular Research;2024-04-18

3. The Fbn1 gene variant governs passive ascending aortic mechanics in the mgΔlpn mouse model of Marfan syndrome when superimposed to perlecan haploinsufficiency;Frontiers in Cardiovascular Medicine;2024-03-13

4. The role of genetic testing in Marfan syndrome;Current Opinion in Cardiology;2024-02-21

5. Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells;Frontiers in Cardiovascular Medicine;2024-02-19